Moderna CEO Stéphane Bancel says company needs to adapt with a mutating coronavirus
Moderna's CEO Stéphane Bancel tells Axios the company's coronavirus vaccine made it to market in near-record time thanks in part to a unique digital foundation.The big picture: Moderna is far smaller than many of its pharma competitors, but it made one of the first authorized COVID-19 vaccines. But the company still needs to adapt to a mutating virus — and come up with its next blockbuster product.Support safe, smart, sane journalism. Sign up for Axios Newsletters here.What they're saying: While Moderna's SARS-CoV-2 vaccine is already beginning to make a dent in...
Source: yahoo.com